Utilizing granulocyte colony-stimulating factor
to enhance vascular graft endothelialization from circulating blood cells.
The publication compares the level of prevention of infection against repeated rectal challenges of simian prototypes of the GeoVax HIV/AIDS vaccine in the presence and absence of granulocyte-macrophage colony-stimulating factor
Granulocyte-macrophage colony-stimulating factor
(GM-CSF) was also administered as an adjuvant in order to stimulate the immune system.
Prior to her recent work as a product development manager for the stem cell growth factor program at Amgen, Zsebo was a research scientist on the team that brought granulocyte colony-stimulating factor
into clinical trials.
This research finding may permit the development of a universal hematopoietic (blood and immune system) stem cell product that could be used with differentiation factors such as granulocyte colony-stimulating factor
(GCSF) and erythropoietin (EPO) to treat a broad variety of disorders, including infections, malignancies and anemia.
issued to Chugai relating to granulocyte colony-stimulating factor
BUSINESS WIRE)--March 7, 1996--Amgen (NASDAQ:AMGN) Thursday announced that its recombinant granulocyte colony-stimulating factor
(rHuG-CSF) NEUPOGEN(R) (Filgrastim) has been approved for use in the United Kingdom as a supportive therapy to treat neutropenia in people with advanced HIV infection, enabling them to receive myelosuppressive therapies.
28, 1995--Amgen (NASDAQ:AMGN) today announced that NEUPOGEN (R) (Filgrastim), the company's recombinant granulocyte colony-stimulating factor
, has been approved for its fourth indication and the third received in 18 months.
Growth factors, primarily erythropoietins and colony-stimulating factors
, represented 35.
Multikine is an immunotherapeutic agent consisting of a mixture of naturally occurring cytokines, including interleukins, interferons, chemokines and colony-stimulating factors
, currently being developed for treatment of cancer.
Related to this issue is the ultimate impact of colony-stimulating factors
in reducing the length of stay and, thus, the costs associated with HDCT-ABMT.
For the purpose of this report, the biosimilars market is categorized into, erythropoietins, human growth hormone (HGH), granulocyte colony-stimulating factors
(G-CSF), low-molecular-weight heparins (LMWH) and other biosimilars.
(CSFs): CSFs reduce the severity and duration of neutropenia, febrile neutropenia, and infection in adults and children who receive chemotherapy for cancer but do not affect infection-related mortality or overall survival.
19, 2014 /PRNewswire/ -- Decision Resources Group finds that sales of biosimilar versions of the granulocyte colony-stimulating factors
(G-CSFs) filgrastim, which is currently pending FDA approval, and pegfilgrastim could reach $1.
Table 2: World Market for Erythropoietins (2000-2010): Geographic Regions Ranked by CAGR - Europe, US, Japan and Rest of World (includes corresponding Graph/Chart) II-14 Colony Stimulating Factors II-14 Granulocyte-Colony Stimulating Factor II-14 Granulocyte Macrophage-Colony Stimulating Factor II-14 Other Colony Stimulating Factors II-14 Macrophage Colony Stimulating Factor (M-CSF) II-15 Key Functions of M-CSF II-15 Side-Effects of Colony-Stimulating Factors